Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000021974 | SCV000220396 | likely pathogenic | Biotinidase deficiency | 2014-06-09 | criteria provided, single submitter | literature only | |
Eurofins Ntd Llc |
RCV000078082 | SCV000230007 | pathogenic | not provided | 2016-06-20 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000078082 | SCV000238755 | pathogenic | not provided | 2022-03-31 | criteria provided, single submitter | clinical testing | Frameshift variant predicted to result in protein truncation, as the last 233 amino acids are replaced with 22 different amino acids, and other loss-of-function variants have been reported downstream in the Human Gene Mutation Database (HGMD); Not observed at a significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 20549359, 9396567, 10400129, 27657684) |
Invitae | RCV000021974 | SCV000630340 | pathogenic | Biotinidase deficiency | 2022-09-26 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Ser311Argfs*23) in the BTD gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 233 amino acid(s) of the BTD protein. This variant is present in population databases (rs397514395, gnomAD 0.002%). This premature translational stop signal has been observed in individual(s) with biotinidase deficiency (PMID: 9396567, 10400129, 12359137, 17185019, 22698809, 25174816, 27657684). ClinVar contains an entry for this variant (Variation ID: 25052). For these reasons, this variant has been classified as Pathogenic. |
ARUP Laboratories, |
RCV000021974 | SCV001473123 | pathogenic | Biotinidase deficiency | 2020-05-27 | criteria provided, single submitter | clinical testing | The BTD c.933delT; p.Ser311fs variant (rs397514395) is reported in the literature in the compound heterozygous state in multiple individuals affected with profound or partial biotinidase deficiency (Borsatto 2014, Milankovics 2007, Pomponio 1997, Wolf 2002, Wolf 2017). This variant is found on only three chromosomes in the Genome Aggregation Database (3/282788 alleles), indicating it is not a common polymorphism. This variant causes a frameshift by deleting a single nucleotide in the last exon of the BTD gene. While this is not expected to lead to nonsense-mediated decay, this is predicted to result in a truncated protein lacking the last 233 amino acids of the BTD protein. Based on available information, this variant is considered to be pathogenic. References: Borsatto T et al. Biotinidase deficiency: clinical and genetic studies of 38 Brazilian patients. BMC Med Genet. 2014;15:96. Milankovics I et al. Mutations causing biotinidase deficiency in children ascertained by newborn screening in Western Hungary. Mol Genet Metab. 2007;90(3):345-348. Pomponio RJ et al. Mutations in the human biotinidase gene that cause profound biotinidase deficiency in symptomatic children: molecular, biochemical, and clinical analysis. Pediatr Res. 1997;42(6):840-848. Wolf B et al. Seventeen novel mutations that cause profound biotinidase deficiency. Mol Genet Metab. 2002;77(1-2):108-111. Wolf B. Successful outcomes of older adolescents and adults with profound biotinidase deficiency identified by newborn screening. Genet Med. 2017;19(4):396-402. |
Ce |
RCV000078082 | SCV001500291 | pathogenic | not provided | 2021-03-01 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV000021974 | SCV002814810 | likely pathogenic | Biotinidase deficiency | 2021-11-24 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV000021974 | SCV004211396 | pathogenic | Biotinidase deficiency | 2023-10-25 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV000021974 | SCV004238793 | pathogenic | Biotinidase deficiency | 2023-06-01 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV000021974 | SCV002081566 | pathogenic | Biotinidase deficiency | 2020-04-06 | no assertion criteria provided | clinical testing |